1. Home
  2. AVXL vs AC Comparison

AVXL vs AC Comparison

Compare AVXL & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • AC
  • Stock Information
  • Founded
  • AVXL 2001
  • AC 1976
  • Country
  • AVXL United States
  • AC United States
  • Employees
  • AVXL N/A
  • AC 25
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • AC Investment Bankers/Brokers/Service
  • Sector
  • AVXL Health Care
  • AC Finance
  • Exchange
  • AVXL Nasdaq
  • AC Nasdaq
  • Market Cap
  • AVXL 779.5M
  • AC 809.6M
  • IPO Year
  • AVXL N/A
  • AC N/A
  • Fundamental
  • Price
  • AVXL $8.35
  • AC $38.06
  • Analyst Decision
  • AVXL Strong Buy
  • AC
  • Analyst Count
  • AVXL 2
  • AC 0
  • Target Price
  • AVXL $44.00
  • AC N/A
  • AVG Volume (30 Days)
  • AVXL 995.5K
  • AC 5.1K
  • Earning Date
  • AVXL 02-12-2025
  • AC 02-05-2025
  • Dividend Yield
  • AVXL N/A
  • AC 5.63%
  • EPS Growth
  • AVXL N/A
  • AC 20.73
  • EPS
  • AVXL N/A
  • AC 2.08
  • Revenue
  • AVXL N/A
  • AC $13,175,000.00
  • Revenue This Year
  • AVXL N/A
  • AC N/A
  • Revenue Next Year
  • AVXL N/A
  • AC N/A
  • P/E Ratio
  • AVXL N/A
  • AC $18.59
  • Revenue Growth
  • AVXL N/A
  • AC 3.88
  • 52 Week Low
  • AVXL $3.25
  • AC $28.58
  • 52 Week High
  • AVXL $14.44
  • AC $43.85
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 40.39
  • AC 55.40
  • Support Level
  • AVXL $8.50
  • AC $36.31
  • Resistance Level
  • AVXL $9.20
  • AC $41.45
  • Average True Range (ATR)
  • AVXL 0.49
  • AC 1.50
  • MACD
  • AVXL -0.01
  • AC 0.11
  • Stochastic Oscillator
  • AVXL 32.23
  • AC 47.54

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About AC Associated Capital Group Inc.

Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.

Share on Social Networks: